Merck receives prestigious R&D 100 Award

Merck has received the R&D 100 Award from R&D magazine.
Merck was honored with the award due to its Sanger Arrayed Lentiviral CRISPR Libraries, which is the first CRISPR library of its kind. R&D Magazine announced the honorees Nov. 3 at its 54th Annual R&D 100 Awards Dinner held in Washington D.C.
"Advancements in gene editing with tools like CRISPR are helping our customers discover and manufacture new treatments for the most difficult conditions," Merck Executive Board member and Life Science CEO Udit Batra said. "We will continue to collaborate with the global scientific community to deliver the promise of their innovations faster and work to accelerate access to health for people everywhere."
Merck has now received an R&D 100 Award for five consecutive years.
Merck’s continued development of innovative products such as its Sanger Arrayed Lentiviral CRISPR Libraries shows its continued dedication to aiding scientists and researchers with the means to create new tools for the improvement of human health.
Known as the “Oscars of Invention,” R&D Magazine’s awards recognize the 100 most groundbreaking scientific and technological breakthroughs of the year.